BCAX insider files Form 144 reporting recent share sales

Ryan Cohlhepp filed a Form 144 reporting sales of Common stock of BCAX.

Rhea-AI Filing Summary

Ryan Cohlhepp filed a Form 144 reporting sales of Common stock of BCAX. The filing lists multiple dispositions in the past three months with dates, share counts, and aggregate sale amounts. Transactions include 12/15/2025: 12,500 shares for $233,547.50, 01/15/2026: 149 shares for $2,684.98, 01/22/2026: 3,828 shares for $69,295.99, and 02/25/2026: 3,631 shares for $69,132.42.

The filing also shows exercises of stock options settled in cash with issuer deliveries: 05/12/2024: 4,500 shares and 03/03/2026: 12,892 shares. The broker listed is UBS Financial Services, Inc.

Insights

Securities Compliance Attorney

Form 144 discloses proposed or completed sales by an affiliate under Section 15(a) notice requirements.

The entries show multiple dispositions by Ryan Cohlhepp with exact share counts and proceeds: 12,500 shares ($233,547.50) on 12/15/2025 and three smaller trades in 01/2026–02/2026. These are standard sale notices that signal compliance with resale reporting obligations.

Timing and settlement details are specific to each row; subsequent filings or broker confirmations would record final settlement. Cash-flow treatment and whether all sales were executed versus proposed are not further specified in the excerpt.

Equity Markets Analyst

Transactions represent insider liquidity events rather than corporate actions; amounts are modest in isolation.

The filing lists option exercises resulting in issuer-delivered common shares on 05/12/2024 (4,500 shares) and 03/03/2026 (12,892 shares). The past-three-month sales aggregate to documented proceeds totaling the sums shown next to each trade date.

These entries do not disclose material corporate developments or changes to business operations; market impact depends on the holder's future disposition decisions and is not specified here.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did the Form 144 filed for BCAX disclose about insider sales?

It discloses multiple sales by Ryan Cohlhepp, listing share counts and proceeds for each trade. The filing lists specific transactions: 12,500 shares for $233,547.50 on 12/15/2025 and three trades in January–February 2026 with amounts shown.

Who is the broker listed on the BCAX Form 144 filing?

The broker shown is UBS Financial Services, Inc. with an address at Eleven Madison Avenue, New York. That broker is named in the securities and sales sections of the filing excerpt.

Are there option exercises reported in the BCAX excerpt?

Yes. The excerpt lists cash-settled option exercises delivering issuer common shares on 05/12/2024 (4,500 shares) and 03/03/2026 (12,892 shares). These exercise entries appear alongside the sale records.

How many shares did Ryan Cohlhepp sell on 12/15/2025 per the filing?

The filing reports a sale of 12,500 shares by Ryan Cohlhepp on 12/15/2025 with aggregate proceeds of $233,547.50 as shown in the transaction row.

Does the Form 144 excerpt state whether the listed sales were completed or only proposed?

The excerpt lists transaction dates, share counts, and proceeds but does not explicitly state completion status for each line. Settlement or execution confirmations are not provided within the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/03/2026 - 04:09 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002034665
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Bicara Therapeutics Inc.
SEC File Number	001-42271
Address of Issuer	116 HUNTINGTON AVENUE SUITE 703 BOSTON MASSACHUSETTS 02116
Phone	617-468-4219
Name of Person for Whose Account the Securities are To Be Sold	Cohlhepp Ryan
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services, Inc Eleven Madison Avenue 4th Floor New York NY 10010	17392	315892.63	54781950	03/03/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/12/2024	Exercise of Stock Option	Issuer			4500	05/12/2024	Cash
Common	03/03/2026	Exercise of Stock Option	Issuer			12892	03/03/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Ryan Cohlhepp 116 HUNTINGTON AVENUE SUITE 703 Boston MA 02116	Common	12/15/2025	12500	233547.50
Ryan Cohlhepp 116 HUNTINGTON AVENUE SUITE 703 Boston MA 02116	Common	01/15/2026	149	2684.98
Ryan Cohlhepp 116 HUNTINGTON AVENUE, SUITE 703 Boston MA 02116	Common	01/22/2026	3828	69295.99
Ryan Cohlhepp 116 Huntington Avenue Suite 703 Bboston MA 02116	Common	02/25/2026	3631	69132.42

144: Remarks and Signature

Remarks
Date of Notice	03/03/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/12/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc., as attorney-in-fact for Ryan Cohlhepp
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)